求助PDF
{"title":"Clinical characteristics of patients with COVID-19 in asian countries","authors":"Nur Khairiah Binti Mohammad Kamel, Nurul Darleena Binti Norshaidi, A. Kuhapiriyan, L. Nadarajan, Nur Batrisyia Husna Binti Zainurin, Salha Pentawinata Hamid, H. Husin, S. Attalla","doi":"10.5958/0974-4614.2020.00040.6","DOIUrl":null,"url":null,"abstract":"Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] has been identified as the cause of an outbreak of respiratory illness in Wuhan, China beginning December 2019 As of 14th July 2020, the pandemic recorded 12,964,809 confirmed cases with 570,288 deaths globally A thorough review of the clinical characteristics of this infection will help in understanding this widespread but seemingly localizing disease This research aimed to review the clinical characteristic of Covid-19 including the risk factors, clinical manifestations, laboratory and radiological findings and complications exhibited in Asia A narrative review was conducted along with 48 research articles published in Scopus journals in 2020 in Asian countries on clinical characteristics of the disease It was concluded that despite being in the same region, clinical characteristics of COVID-19 varies among the Asian countries The mortality rate among Asian countries was varied with the competency of public health measures as one of the vital contributing factors The variable findings on the clinical characteristics may be due to inconsistent quality of methodology in recent researches which was a rapid response to the pandemic Although these studies are necessary to manage the current global emergency, more high-quality researches are needed to provide a valid and reliable scientific understanding of the disease © 2020, All India Institute of Medical Sciences All rights reserved","PeriodicalId":14091,"journal":{"name":"International Journal of Medical Toxicology and Legal Medicine","volume":"19 1","pages":"18-28"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Medical Toxicology and Legal Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5958/0974-4614.2020.00040.6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
引用
批量引用
亚洲国家COVID-19患者临床特征分析
截至2020年7月14日,严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)已被确定为2019年12月开始在中国武汉爆发的呼吸道疾病的原因,对这种感染的临床特征进行全面审查将有助于了解这种广泛但看似局部的疾病。这项研究旨在审查Covid-19的临床特征,包括危险因素、临床表现、对亚洲国家在2020年发表在Scopus期刊上的48篇关于该疾病临床特征的研究文章进行了叙述性审查,得出的结论是,尽管处于同一地区,亚洲各国的COVID-19临床特征各不相同,亚洲各国的死亡率各不相同,公共卫生措施的能力是重要的影响因素之一。临床特征的不同发现可能是由于近期研究方法质量不一致,这些研究是对大流行的快速反应,尽管这些研究对于管理当前的全球紧急情况是必要的,需要更多高质量的研究来提供有效和可靠的疾病科学理解©2020,全印度医学科学研究所保留所有权利
本文章由计算机程序翻译,如有差异,请以英文原文为准。